A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says.

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

A new blood test uses what is known as biomarkers to identify a person’s Alzheimer’s disease status, changing how we monitor ...

The blood test can be used to steer spinal cord patients to treatments that will best serve them, and more quickly get patients with the worst injuries into cutting-edge clinical trials, Azad said.

The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.

By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of ...

He has started prescribing a new kind of screening — the Shield blood test — for his patients who are hesitant to get a colonoscopy. For a decade, we've had stool collection kits like Cologuard.

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, experts said.

Blood tests that can detect 90% of Alzheimer’s cases could revolutionize access to Alzheimer’s treatment, studies say.

(CNN) — A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found. In comparison, neurologists and ...